Harbour Investments, Inc. Galecto, Inc. Transaction History

Harbour Investments, Inc.

  • $3.14 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 22, 2024
BUY
$0.6 - $0.89 $120 - $178
200 New
200 $0
Q4 2021

Feb 16, 2022
SELL
$2.3 - $3.58 $690 - $1,074
-300 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$4.63 - $8.0 $926 - $1,600
200 Added 200.0%
300 $2,000
Q1 2021

Aug 17, 2021
BUY
$6.08 - $13.25 $608 - $1,325
100 New
100 $1,000

Others Institutions Holding GLTO

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0
View Full List

About Galecto, Inc.

GLTO Quotes by TradingView
  • Ticker GLTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,395,700
  • Market Cap $120M
  • Description
  • Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...
More about GLTO
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email